186 related articles for article (PubMed ID: 16675931)
1. Short stature, obesity, and growth hormone deficiency in pseudohypoparathyroidism type 1a.
Germain-Lee EL
Pediatr Endocrinol Rev; 2006 Apr; 3 Suppl 2():318-27. PubMed ID: 16675931
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone deficiency in pseudohypoparathyroidism type 1a: another manifestation of multihormone resistance.
Germain-Lee EL; Groman J; Crane JL; Jan de Beur SM; Levine MA
J Clin Endocrinol Metab; 2003 Sep; 88(9):4059-69. PubMed ID: 12970262
[TBL] [Abstract][Full Text] [Related]
3. Genetic analysis and evaluation of resistance to thyrotropin and growth hormone-releasing hormone in pseudohypoparathyroidism type Ib.
Mantovani G; Bondioni S; Linglart A; Maghnie M; Cisternino M; Corbetta S; Lania AG; Beck-Peccoz P; Spada A
J Clin Endocrinol Metab; 2007 Sep; 92(9):3738-42. PubMed ID: 17595244
[TBL] [Abstract][Full Text] [Related]
4. A mouse model of albright hereditary osteodystrophy generated by targeted disruption of exon 1 of the Gnas gene.
Germain-Lee EL; Schwindinger W; Crane JL; Zewdu R; Zweifel LS; Wand G; Huso DL; Saji M; Ringel MD; Levine MA
Endocrinology; 2005 Nov; 146(11):4697-709. PubMed ID: 16099856
[TBL] [Abstract][Full Text] [Related]
5. GH secretion in a cohort of children with pseudohypoparathyroidism type Ia.
de Sanctis L; Bellone J; Salerno M; Faleschini E; Caruso-Nicoletti M; Cicchetti M; Concolino D; Balsamo A; Buzi F; Ghizzoni L; de Sanctis C
J Endocrinol Invest; 2007 Feb; 30(2):97-103. PubMed ID: 17392598
[TBL] [Abstract][Full Text] [Related]
6. Current Nomenclature of Pseudohypoparathyroidism: Inactivating Parathyroid Hormone/Parathyroid Hormone-Related Protein Signaling Disorder.
Turan S
J Clin Res Pediatr Endocrinol; 2017 Dec; 9(Suppl 2):58-68. PubMed ID: 29280743
[TBL] [Abstract][Full Text] [Related]
7. Paternal imprinting of Galpha(s) in the human thyroid as the basis of TSH resistance in pseudohypoparathyroidism type 1a.
Germain-Lee EL; Ding CL; Deng Z; Crane JL; Saji M; Ringel MD; Levine MA
Biochem Biophys Res Commun; 2002 Aug; 296(1):67-72. PubMed ID: 12147228
[TBL] [Abstract][Full Text] [Related]
8. Parental Origin of
McMullan P; Maye P; Yang Q; Rowe DW; Germain-Lee EL
JBMR Plus; 2022 Jan; 6(1):e10570. PubMed ID: 35079678
[TBL] [Abstract][Full Text] [Related]
9. [Paternal GNAS mutations: Which phenotypes? What genetic counseling?].
Kottler ML
Ann Endocrinol (Paris); 2015 May; 76(2):105-9. PubMed ID: 25952723
[TBL] [Abstract][Full Text] [Related]
10. Pseudohypoparathyroidism Type 1A-Subclinical Hypothyroidism and Rapid Weight Gain as Early Clinical Signs: A Clinical Review of 10 Cases.
Kayemba-Kay's S; Tripon C; Heron A; Hindmarsh P
J Clin Res Pediatr Endocrinol; 2016 Dec; 8(4):432-438. PubMed ID: 27467896
[TBL] [Abstract][Full Text] [Related]
11. Endocrine manifestations of stimulatory G protein alpha-subunit mutations and the role of genomic imprinting.
Weinstein LS; Yu S; Warner DR; Liu J
Endocr Rev; 2001 Oct; 22(5):675-705. PubMed ID: 11588148
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone-releasing hormone resistance in pseudohypoparathyroidism type ia: new evidence for imprinting of the Gs alpha gene.
Mantovani G; Maghnie M; Weber G; De Menis E; Brunelli V; Cappa M; Loli P; Beck-Peccoz P; Spada A
J Clin Endocrinol Metab; 2003 Sep; 88(9):4070-4. PubMed ID: 12970263
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone deficiency in monozygotic twins with autosomal dominant pseudohypoparathyroidism type Ib.
Sano S; Iwata H; Matsubara K; Fukami M; Kagami M; Ogata T
Endocr J; 2015; 62(6):523-9. PubMed ID: 25843330
[TBL] [Abstract][Full Text] [Related]
14. Resistance to growth hormone releasing hormone and gonadotropins in Albright's hereditary osteodystrophy.
Mantovani G; Spada A
J Pediatr Endocrinol Metab; 2006 May; 19 Suppl 2():663-70. PubMed ID: 16789632
[TBL] [Abstract][Full Text] [Related]
15. The GNAS locus and pseudohypoparathyroidism.
Bastepe M
Adv Exp Med Biol; 2008; 626():27-40. PubMed ID: 18372789
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of methylation defects and correlation with clinical characteristics in patients with pseudohypoparathyroidism type I and GNAS epigenetic alterations.
Elli FM; de Sanctis L; Bollati V; Tarantini L; Filopanti M; Barbieri AM; Peverelli E; Beck-Peccoz P; Spada A; Mantovani G
J Clin Endocrinol Metab; 2014 Mar; 99(3):E508-17. PubMed ID: 24423294
[TBL] [Abstract][Full Text] [Related]
17. Recombinant growth hormone improves growth and adult height in patients with maternal inactivating GNAS mutations.
Ertl DA; de Nanclares GP; Jüppner H; Hanna P; Pagnano A; Pereda A; Rothenbuhler A; Del Sindaco G; Ruiz-Cuevas P; Audrain C; Escribano A; Berkenou J; Gleiss A; Mantovani G; Linglart A
Eur J Endocrinol; 2023 Jul; 189(1):123-131. PubMed ID: 37440712
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel mutation in a pseudohypoparathyroidism family.
Miao ZM; Wang C; Wang BB; Meng DM; Su DM; Cheng Z; Wen QL; Han L; Yu Q; Ma X; Li CG
Int J Endocrinol; 2011; 2011():509549. PubMed ID: 21822432
[TBL] [Abstract][Full Text] [Related]
19. Pseudohypoparathyroidism type 1a with congenital hypothyroidism.
Pinsker JE; Rogers W; McLean S; Schaefer FV; Fenton C
J Pediatr Endocrinol Metab; 2006 Aug; 19(8):1049-52. PubMed ID: 16995592
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
